These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 21303658

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis.
    Guyton MK, Wingrave JM, Yallapragada AV, Wilford GG, Sribnick EA, Matzelle DD, Tyor WR, Ray SK, Banik NL.
    J Neurosci Res; 2005 Jul 01; 81(1):53-61. PubMed ID: 15952172
    [Abstract] [Full Text] [Related]

  • 4. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG, Voda J, Yu X, McKeon G, Bourdette DN.
    J Neurosci Res; 2004 Aug 01; 77(3):367-77. PubMed ID: 15248293
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 2-(2-Benzofuranyl)-2-Imidazoline Attenuates the Disruption of the Blood-Brain Barrier in EAE via NMDAR.
    Xia N, Hua Y, Li J, Chen Y, Li X, Lin J, Xu H, Xie C, Wang X.
    Neurochem Res; 2021 Jul 01; 46(7):1674-1685. PubMed ID: 33772673
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
    Kanwar JR, Kanwar RK, Krissansen GW.
    Brain; 2004 Jun 01; 127(Pt 6):1313-31. PubMed ID: 15130951
    [Abstract] [Full Text] [Related]

  • 9. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
    Wang XS, Chen YY, Shang XF, Zhu ZG, Chen GQ, Han Z, Shao B, Yang HM, Xu HQ, Chen JF, Zheng RY.
    Brain Res; 2009 Feb 09; 1253():198-209. PubMed ID: 19083996
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
    Black JA, Liu S, Hains BC, Saab CY, Waxman SG.
    Brain; 2006 Dec 09; 129(Pt 12):3196-208. PubMed ID: 16931536
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE).
    Musgrave T, Benson C, Wong G, Browne I, Tenorio G, Rauw G, Baker GB, Kerr BJ.
    Brain Behav Immun; 2011 Nov 09; 25(8):1677-88. PubMed ID: 21723939
    [Abstract] [Full Text] [Related]

  • 17. Gonadotropin-releasing hormone reduces the severity of experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Quintanar JL, Salinas E, Quintanar-Stephano A.
    Neuropeptides; 2011 Feb 09; 45(1):43-8. PubMed ID: 21056467
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.